ILC 2016:与酒精性肝炎相关的基因:PNPLA3和SLC38A4

2016-04-10 Mechront 译 MedSci原创

2016年国际肝病会议称,PNPLA3和SLC38A4基因的特定突变+重度饮酒会增加酒精性肝炎风险。来自英国伦敦帝国学院内科研究人员Stephen Atkinson博士和同事假设遗传因素会影响严重的酒精性肝炎的发展。他们对超过2,000名患者进行了全基因组研究,比较遗传差异。其中包括了860名严重酒精性肝炎和1,191名依赖酒精但没有酒精性肝炎的对照组患者。结果显示,PNPLA3基因的变异rs73

2016年国际肝病会议称,PNPLA3和SLC38A4基因的特定突变+重度饮酒会增加酒精性肝炎风险。

来自英国伦敦帝国学院内科研究人员Stephen Atkinson博士和同事假设遗传因素会影响严重的酒精性肝炎的发展。他们对超过2,000名患者进行了全基因组研究,比较遗传差异。其中包括了860名严重酒精性肝炎和1,191名依赖酒精但没有酒精性肝炎的对照组患者。

结果显示,PNPLA3基因的变异rs738409是严重酒精性肝炎强烈的风险因素(OR = 2.21)。SLC38A4基因是酒精性肝炎的一个新的独立的风险位点或指标(OR = 1.32)。

Atkinson写道,PNPLA3和SLC38A4基因的突变是很常见的,分别约有四分之一和二分之一的人群具有相对基因的突变。先前的研究就表明了PNPLA3基因突变与酒精性肝炎密切相关,而SLC38A4基因则是本研究发现的新的标志物。

他认为基因的研究将为我们带来新的视角,不管是对酒精性肝炎的认识上,还是特定的治疗上,更好的服务于医疗和患者。

原始出处:

Atkinson S, et al. Abstract GS03. Presented at: International Liver Congress; April 13-17, 2016; Barcelona.

Alcoholism plus variants in PNPLA3, SLC38A4 increase risk for alcoholic hepatitis.Healio.April 14, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675245, encodeId=c0c216e5245bc, content=<a href='/topic/show?id=b9f214438ea' target=_blank style='color:#2F92EE;'>#PNP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14438, encryptionId=b9f214438ea, topicName=PNP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b29b27191603, createdName=cy0333, createdTime=Tue Jan 17 00:59:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978100, encodeId=5e0719e8100cd, content=<a href='/topic/show?id=c0bc1443962' target=_blank style='color:#2F92EE;'>#PNPLA3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14439, encryptionId=c0bc1443962, topicName=PNPLA3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Aug 27 18:59:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673255, encodeId=586816e325502, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 14 14:59:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540349, encodeId=1cca15403497a, content=<a href='/topic/show?id=9aa195483ab' target=_blank style='color:#2F92EE;'>#酒精性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95483, encryptionId=9aa195483ab, topicName=酒精性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1413208885, createdName=xue8606, createdTime=Tue Apr 12 13:59:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2017-01-17 cy0333
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675245, encodeId=c0c216e5245bc, content=<a href='/topic/show?id=b9f214438ea' target=_blank style='color:#2F92EE;'>#PNP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14438, encryptionId=b9f214438ea, topicName=PNP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b29b27191603, createdName=cy0333, createdTime=Tue Jan 17 00:59:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978100, encodeId=5e0719e8100cd, content=<a href='/topic/show?id=c0bc1443962' target=_blank style='color:#2F92EE;'>#PNPLA3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14439, encryptionId=c0bc1443962, topicName=PNPLA3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Aug 27 18:59:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673255, encodeId=586816e325502, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 14 14:59:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540349, encodeId=1cca15403497a, content=<a href='/topic/show?id=9aa195483ab' target=_blank style='color:#2F92EE;'>#酒精性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95483, encryptionId=9aa195483ab, topicName=酒精性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1413208885, createdName=xue8606, createdTime=Tue Apr 12 13:59:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675245, encodeId=c0c216e5245bc, content=<a href='/topic/show?id=b9f214438ea' target=_blank style='color:#2F92EE;'>#PNP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14438, encryptionId=b9f214438ea, topicName=PNP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b29b27191603, createdName=cy0333, createdTime=Tue Jan 17 00:59:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978100, encodeId=5e0719e8100cd, content=<a href='/topic/show?id=c0bc1443962' target=_blank style='color:#2F92EE;'>#PNPLA3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14439, encryptionId=c0bc1443962, topicName=PNPLA3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Aug 27 18:59:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673255, encodeId=586816e325502, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 14 14:59:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540349, encodeId=1cca15403497a, content=<a href='/topic/show?id=9aa195483ab' target=_blank style='color:#2F92EE;'>#酒精性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95483, encryptionId=9aa195483ab, topicName=酒精性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1413208885, createdName=xue8606, createdTime=Tue Apr 12 13:59:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675245, encodeId=c0c216e5245bc, content=<a href='/topic/show?id=b9f214438ea' target=_blank style='color:#2F92EE;'>#PNP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14438, encryptionId=b9f214438ea, topicName=PNP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b29b27191603, createdName=cy0333, createdTime=Tue Jan 17 00:59:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978100, encodeId=5e0719e8100cd, content=<a href='/topic/show?id=c0bc1443962' target=_blank style='color:#2F92EE;'>#PNPLA3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14439, encryptionId=c0bc1443962, topicName=PNPLA3)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Aug 27 18:59:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673255, encodeId=586816e325502, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 14 14:59:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540349, encodeId=1cca15403497a, content=<a href='/topic/show?id=9aa195483ab' target=_blank style='color:#2F92EE;'>#酒精性肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95483, encryptionId=9aa195483ab, topicName=酒精性肝炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1413208885, createdName=xue8606, createdTime=Tue Apr 12 13:59:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]

相关资讯

EASL 2014:难辨梭菌感染增加酒精性肝炎死亡率

合并感染的酒精性肝炎(AH)患者死亡率较无感染者增加,但目前尚无资料表明日益增多的难辨梭状芽孢杆菌感染(CDI)对AH患者的影响。 美国洛杉矶加利福尼亚大学席达西尼医学中心的Sundaram等进行了一项研究,旨在探讨AH与CDI的相关性,以及合并梭状芽孢杆菌感染AH患者的住院周期及费用问题。 研究从全国住院样本数据库中检索出AH患者,应用多因素回归分析住院患者发生CDI的高危因素及AH患者死亡的危

酒精性肝炎Maddrey判别函数计算公式

酒精性肝炎Maddrey判别函数计算公式

Gastroenterology:强化肠内营养并不能改善重型酒精性肝炎患者生存期

重型酒精性肝炎(AH)是一种危及生命的疾病,该疾病的治疗需要有足够的口服营养支持。研究者进行了一项随机对照试验,探究重型AH的治疗里使用强化的肠内营养能否改善疗效。该研究共纳入了136名18-75岁重度饮酒者,近期出现黄疸表现,且活组织病检确诊为重型AH的患者。按1:1随机分为以下两种治疗方案组:强化的肠内营养+甲基强的松龙(试验组)、传统的营养+甲基强的松龙(对照组)。强化的肠内营养患者通过鼻胃

格拉斯哥酒精性肝炎评分公式

格拉斯哥酒精性肝炎评分公式